1-8 of 8
Authors: Godwin C. Enwere
Save search
Sort by
Journal Article

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays Free

PDF
Gregory A. Price and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S554–S562, https://doi.org/10.1093/cid/civ504
Published: 09 November 2015
Journal Article

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons Open Access

PDF
Godwin C. Enwere and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S501–S506, https://doi.org/10.1093/cid/civ509
Published: 09 November 2015
Journal Article

Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials Open Access

PDF
Olubukola T. Idoko and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S416–S421, https://doi.org/10.1093/cid/civ596
Published: 09 November 2015
Journal Article

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali Open Access

PDF
Panchali Roy Chowdhury and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S586–S593, https://doi.org/10.1093/cid/civ603
Published: 09 November 2015
Journal Article

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians Open Access

PDF
Milagritos D. Tapia and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S507–S513, https://doi.org/10.1093/cid/civ626
Published: 09 November 2015
Journal Article

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age Open Access

PDF
Milagritos D. Tapia and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S514–S520, https://doi.org/10.1093/cid/civ672
Published: 09 November 2015
Journal Article

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years Open Access

PDF
Aldiouma Diallo and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S521–S530, https://doi.org/10.1093/cid/civ518
Published: 09 November 2015
Journal Article

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine Open Access

PDF
Lionel Martellet and others
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015, Pages S422–S427, https://doi.org/10.1093/cid/civ598
Published: 09 November 2015